Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederclinicaltrials.gov
ClinicalTrials.gov: Glioma OR Astrocytoma OR Oligodendroglioma | Other terms: IDH Mutation | Interventional, Expanded Access studies | Last update posted in the last 14 days
Get the latest updates from ClinicalTrials.gov: Glioma OR Astrocytoma OR Oligodendroglioma | Other terms: IDH Mutation | Interventional, Expanded Access studies | Last update posted in the last 14 days directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 2 days ago
Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR
4 days ago
Conditions: Brain Tumor; Cervical Cancer Interventions: Drug: 18F-FTX Sponsors: M.D. Anderson Cancer...
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
4 days ago
Conditions: Astrocytoma, IDH-Mutant, Grade 3 Interventions: Radiation: Intensity-Modulated Radiation Therapy; Radiation: Volume...
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
10 days ago
Conditions: Glioblastoma; Adult-type Diffuse Gliomas Interventions: Drug: Pemigatinib Sponsors: Incyte Corporation Terminated
Chronic CED of TPT for Recurrent Malignant Glioma
12 days ago
Conditions: Brain Tumor, Recurrent; Malignant Glioma (WHO Grade III or IV); IDH1/IDH2...
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
16 days ago
Conditions: Brain Tumor; Cancer Interventions: Drug: Zotiraciclib Sponsors: National Cancer Institute (NCI)...
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
18 days ago
Conditions: Brain Tumor; Cancer Interventions: Drug: Zotiraciclib Sponsors: National Cancer Institute (NCI)...
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
19 days ago
Conditions: Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma Interventions...
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
24 days ago
Conditions: Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma Interventions...
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
26 days ago
Conditions: Glioma; IDH Mutation; Astrocytoma; Oligodendroglioma Interventions: Drug: Retifanlimab; Drug: All-trans retinoic...
Study of How Safe and Effective Tarlatamab is in Brain Cancers
29 days ago
Conditions: Astrocytic Tumor; Oligodendroglial Tumor Interventions: Drug: Tarlatamab Sponsors: University Health Network...
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.
29 days ago
Conditions: Glioma Interventions: Biological: Biological: personalized vaccine Based on genetic and transcriptional...
A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations
about 1 month ago
Conditions: Isocitrate Dehydrogenase Gene Mutation Interventions: Drug: HMPL-306 Sponsors: Hutchmed Terminated